Skip to Main Content
Beta test
our new site.
(
NLM Technical Bulletin
)
Home
Search
Study Topics
Glossary
Full Text View
Tabular View
No Study Results Posted
Related Studies
Immunogenicity and Safety Study of Proquad® and Infanrix® Hexa When Administered Concomitantly
This study has been completed.
Study NCT00432042 Information provided by Sanofi Pasteur MSD
First Received on February 5, 2007. Last Updated on April 3, 2009
History of Changes
Related Studies can be found by searching for the Conditions, Interventions, and Sponsors found in this study:
Conditions listed in this trial
Varicella
Measles
Mumps
Rubella
Diphtheria
Tetanus
Pertussis
Poliomyelitis
Hepatitis B
Haemophilus Infections
Additional conditions recognized in this trial
Chickenpox
Hepatitis
Hepatitis A
Herpes Zoster
Parotitis
Whooping Cough
More general conditions related to this trial
Actinomycetales Infections
Bacterial Infections
Bordetella Infections
Central Nervous System Diseases
Central Nervous System Infections
Central Nervous System Viral Diseases
Clostridium Infections
Corynebacterium Infections
Digestive System Diseases
DNA Virus Infections
Enterovirus Infections
Gram-Negative Bacterial Infections
Gram-Positive Bacterial Infections
Hepadnaviridae Infections
Hepatitis, Viral, Human
Herpesviridae Infections
Infection
Liver Diseases
Mononegavirales Infections
Morbillivirus Infections
Mouth Diseases
Myelitis
Nervous System Diseases
Neuromuscular Diseases
Paramyxoviridae Infections
Parotid Diseases
Pasteurellaceae Infections
Picornaviridae Infections
Respiratory Tract Diseases
Respiratory Tract Infections
RNA Virus Infections
Rubivirus Infections
Rubulavirus Infections
Salivary Gland Diseases
Sialadenitis
Spinal Cord Diseases
Stomatognathic Diseases
Togaviridae Infections
Virus Diseases
Interventions listed in this trial
ProQuad® and Infanrix® hexa
Sponsors listed in this trial
Sanofi Pasteur MSD
Back to top of Main Content
